PAA 2.56% 20.0¢ pharmaust limited

Clinical Trials, page-298

  1. 642 Posts.
    lightbulb Created with Sketch. 111
    If PAA is a TO target, who buys? Has to be Eli Lilly, yeah? I’m just thinking about what Sep/Oct call options to punt on. Eli Lilly at least doubles its MC with help from the Robinhood crowd over there.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.